搜索临床试验以:anti-IL-23 therapy
总计154166个结果
-
GlaxoSmithKline完全的
-
Washington University School of MedicineAmerican Diabetes Association撤销
-
Provectus Biopharmaceuticals, Inc.不再可用
-
Centre Oscar LambretHôpital Gériatrique Les Bateliers, CHRU Lille完全的
-
Children's Hospital Medical Center, Cincinnati完全的
-
Almirall, S.A.主动,不招人
-
McDaniel Institute of Anti-Aging ResearchAllergan; Merz Aesthetics Inc.; ThermiGen, LLC未知
-
Icahn School of Medicine at Mount SinaiBristol-Myers Squibb完全的
-
Tetraphase Pharmaceuticals, Inc.Department of Health and Human Services完全的
-
University Hospital, Bordeaux完全的
-
Bristol-Myers Squibb主动,不招人按部位分类的肿瘤美国, 澳大利亚, 丹麦, 法国, 瑞士, 奥地利, 加拿大, 德国, 日本, 荷兰, 挪威, 西班牙, 英国, 芬兰, 意大利
-
Rambam Health Care Campus未知Group A- 23 Implant Using Switch Platform -SPK Abutment. | Group B- 22 Implant Using the Traditional -CPK Abutment.以色列
-
Carlos WambierBrown University; Sun Pharmaceutical Industries Limited; Lifespan; Ocean State Research Institute...主动,不招人
-
Cardiovascular Academy Society, Turkey完全的
-
Istituto Ortopedico Galeazzi完全的
-
Chiang Mai University完全的
-
Creighton UniversityNovartis Pharmaceuticals完全的
-
Jason J. Luke, MDBristol-Myers Squibb招聘中
-
Humanis Saglık Anonim Sirketi完全的
-
University of Georgia招聘中消息曝光(顺序:Regular Then Flavor) | 消息曝光(顺序:Flavor Then Regular) | 无消息暴露(控制条件)美国
-
Shanghai Huaota Biopharmaceutical Co., Ltd.招聘中
-
Medical University of ViennaCharite University, Berlin, Germany; University of Alberta; CSL Behring完全的
-
Shanghai Junshi Bioscience Co., Ltd.Sponsor GmbH招聘中